26/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0. Gray context columns never affect the score. CEO quarterly pay is the explicitly marked annual ÷ 4 estimate.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly. Unavailable evidence scores 0 only in Win/Lose columns; gray columns award no points.
| Quarter | Total return | Revenue growth | EPS growth | Net marginNon-scoring | Trailing P/ENon-scoring | Price/bookNon-scoring | CEO quarterly payNon-scoring | Implied DilutionNon-scoring | Implied BuybackNon-scoring |
|---|---|---|---|---|---|---|---|---|---|
| 2026-Q21/3 |
WinCRI / S&P 15.88% / 15.20% |
LoseCRI / S&P 5.17% / 15.00% |
LoseCRI / S&P 42.18% / 50.40% |
Non-scoringCRI / S&P 6.55% / 15.70% | Non-scoringCRI / S&P 7.65 / 28.47 | Non-scoringCRI / S&P 1.45 / S&P unavailable | Non-scoringCRI / S&P CRI unavailable / S&P unavailable | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.36b |
| 2026-Q11/3 |
WinCRI / S&P 11.07% / -4.33% |
LoseCRI / S&P 4.88% / 11.30% |
LoseCRI / S&P -44.69% / 27.70% |
Non-scoringCRI / S&P 3.07% / 14.80% | Non-scoringCRI / S&P 14.61 / 25.43 | Non-scoringCRI / S&P 1.43 / S&P unavailable | Non-scoringCRI / S&P CRI unavailable / S&P unavailable | Non-scoringCRI / S&P CRI unavailable / $0.27b | Non-scoringCRI / S&P CRI unavailable / $0.00b |
| 2025-Q41/3 |
WinCRI / S&P 15.88% / 2.65% |
LoseCRI / S&P 1.91% / 9.00% |
LoseCRI / S&P -50.49% / 13.40% |
Non-scoringCRI / S&P 3.17% / 13.20% | Non-scoringCRI / S&P 13.17 / 28.48 | Non-scoringCRI / S&P 1.31 / 5.39 | Non-scoringCRI / S&P CRI unavailable / $4.42m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.20b |
| 2025-Q30/3 |
LoseCRI / S&P -5.45% / 8.12% |
LoseCRI / S&P -0.34% / 4.61% |
LoseCRI / S&P -60.79% / 13.45% |
Non-scoringCRI / S&P 3.15% / 11.78% | Non-scoringCRI / S&P 11.97 / 28.13 | Non-scoringCRI / S&P 1.23 / 5.27 | Non-scoringCRI / S&P CRI unavailable / $4.42m | Non-scoringCRI / S&P CRI unavailable / $0.11b | Non-scoringCRI / S&P CRI unavailable / $0.00b |
| 2025-Q20/3 |
LoseCRI / S&P -25.74% / 10.94% |
LoseCRI / S&P -1.46% / 4.83% |
LoseCRI / S&P -41.64% / 10.63% |
Non-scoringCRI / S&P 4.79% / 11.45% | Non-scoringCRI / S&P 8.07 / 27.10 | Non-scoringCRI / S&P 1.28 / 5.01 | Non-scoringCRI / S&P CRI unavailable / $4.42m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.23b |
| 2025-Q10/3 |
LoseCRI / S&P -23.04% / -4.27% |
LoseCRI / S&P -3.39% / 4.98% |
LoseCRI / S&P -28.71% / 10.57% |
Non-scoringCRI / S&P 5.80% / 11.39% | Non-scoringCRI / S&P 8.99 / 26.23 | Non-scoringCRI / S&P 1.73 / 4.69 | Non-scoringCRI / S&P CRI unavailable / $4.42m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.10b |
| 2024-Q40/3 |
LoseCRI / S&P -15.35% / 2.41% |
LoseCRI / S&P -3.45% / 5.25% |
LoseCRI / S&P -17.92% / 6.15% |
Non-scoringCRI / S&P 6.52% / 11.29% | Non-scoringCRI / S&P 10.58 / 28.60 | Non-scoringCRI / S&P 2.30 / 4.99 | Non-scoringCRI / S&P CRI unavailable / $4.28m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.08b |
| 2024-Q32/3 |
WinCRI / S&P 6.10% / 5.89% |
LoseCRI / S&P -5.25% / 5.89% |
WinCRI / S&P 15.60% / 6.11% |
Non-scoringCRI / S&P 8.11% / 10.87% | Non-scoringCRI / S&P 10.42 / 28.09 | Non-scoringCRI / S&P 2.90 / 4.94 | Non-scoringCRI / S&P CRI unavailable / $4.28m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.21b |
| 2024-Q21/3 |
LoseCRI / S&P -25.92% / 4.28% |
LoseCRI / S&P -5.00% / 5.38% |
WinCRI / S&P 20.97% / 5.12% |
Non-scoringCRI / S&P 8.29% / 10.85% | Non-scoringCRI / S&P 9.43 / 27.64 | Non-scoringCRI / S&P 2.77 / 4.79 | Non-scoringCRI / S&P CRI unavailable / $4.28m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.36b |
| 2024-Q12/3 |
WinCRI / S&P 14.17% / 10.56% |
LoseCRI / S&P -6.91% / 5.71% |
WinCRI / S&P 12.61% / 5.59% |
Non-scoringCRI / S&P 8.06% / 10.81% | Non-scoringCRI / S&P 13.21 / 27.02 | Non-scoringCRI / S&P 3.68 / 4.71 | Non-scoringCRI / S&P CRI unavailable / $4.28m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.12b |
| 2023-Q40/3 |
LoseCRI / S&P 9.51% / 11.69% |
LoseCRI / S&P -8.32% / 6.81% |
LoseCRI / S&P -1.42% / 7.78% |
Non-scoringCRI / S&P 7.89% / 11.19% | Non-scoringCRI / S&P 11.77 / 24.35 | Non-scoringCRI / S&P 3.24 / 4.31 | Non-scoringCRI / S&P CRI unavailable / $4.08m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.01b |
| 2023-Q30/3 |
LoseCRI / S&P -3.72% / -3.27% |
LoseCRI / S&P -10.79% / 7.52% |
LoseCRI / S&P -16.92% / -5.03% |
Non-scoringCRI / S&P 6.87% / 10.84% | Non-scoringCRI / S&P 12.40 / 23.93 | Non-scoringCRI / S&P 3.26 / 3.98 | Non-scoringCRI / S&P CRI unavailable / $4.08m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.24b |
| 2023-Q20/3 |
LoseCRI / S&P 2.16% / 8.74% |
LoseCRI / S&P -11.87% / 9.50% |
LoseCRI / S&P -21.70% / -8.57% |
Non-scoringCRI / S&P 6.77% / 10.88% | Non-scoringCRI / S&P 13.23 / 24.01 | Non-scoringCRI / S&P 3.50 / 4.19 | Non-scoringCRI / S&P CRI unavailable / $4.08m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.17b |
| 2023-Q10/3 |
LoseCRI / S&P -2.63% / 7.50% |
LoseCRI / S&P -10.14% / 10.77% |
LoseCRI / S&P -25.03% / -15.69% |
Non-scoringCRI / S&P 6.97% / 10.82% | Non-scoringCRI / S&P 12.46 / 22.66 | Non-scoringCRI / S&P 3.41 / 3.93 | Non-scoringCRI / S&P CRI unavailable / $4.08m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.13b |
| 2022-Q41/3 |
WinCRI / S&P 15.00% / 7.56% |
LoseCRI / S&P -7.85% / 11.88% |
LoseCRI / S&P -18.82% / -17.99% |
Non-scoringCRI / S&P 7.78% / 11.09% | Non-scoringCRI / S&P 11.25 / 22.65 | Non-scoringCRI / S&P 3.53 / 3.75 | Non-scoringCRI / S&P CRI unavailable / $3.70m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.15b |
| 2022-Q30/3 |
LoseCRI / S&P -6.07% / -4.88% |
LoseCRI / S&P -1.51% / 13.47% |
LoseCRI / S&P -15.57% / -1.41% |
Non-scoringCRI / S&P 7.94% / 12.28% | Non-scoringCRI / S&P 9.44 / 20.58 | Non-scoringCRI / S&P 3.20 / 3.60 | Non-scoringCRI / S&P CRI unavailable / $3.70m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.17b |
| 2022-Q20/3 |
LoseCRI / S&P -22.64% / -16.10% |
LoseCRI / S&P 1.36% / 13.71% |
LoseCRI / S&P -11.31% / 11.04% |
Non-scoringCRI / S&P 8.35% / 13.03% | Non-scoringCRI / S&P 9.70 / 20.28 | Non-scoringCRI / S&P 3.39 / 3.78 | Non-scoringCRI / S&P CRI unavailable / $3.70m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.17b |
| 2022-Q10/3 |
LoseCRI / S&P -8.40% / -4.60% |
LoseCRI / S&P 10.23% / 15.97% |
LoseCRI / S&P 19.97% / 42.23% |
Non-scoringCRI / S&P 9.24% / 14.22% | Non-scoringCRI / S&P 11.25 / 22.19 | Non-scoringCRI / S&P 3.95 / 4.51 | Non-scoringCRI / S&P CRI unavailable / $3.70m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.20b |
| 2021-Q42/3 |
LoseCRI / S&P 4.69% / 11.03% |
WinCRI / S&P 15.28% / 15.00% |
WinCRI / S&P 214.92% / 96.40% |
Non-scoringCRI / S&P 9.74% / 15.13% | Non-scoringCRI / S&P 12.26 / 23.63 | Non-scoringCRI / S&P 4.38 / 4.73 | Non-scoringCRI / S&P CRI unavailable / $3.63m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.13b |
| 2021-Q31/3 |
LoseCRI / S&P -5.38% / 0.58% |
LoseCRI / S&P 8.91% / 10.77% |
WinCRI / S&P 158.14% / 69.42% |
Non-scoringCRI / S&P 10.01% / 14.13% | Non-scoringCRI / S&P 12.50 / 25.35 | Non-scoringCRI / S&P 4.05 / 4.38 | Non-scoringCRI / S&P CRI unavailable / $3.63m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.19b |
| 2021-Q22/3 |
WinCRI / S&P 16.46% / 8.55% |
LoseCRI / S&P 5.46% / 6.58% |
WinCRI / S&P 207.60% / 51.81% |
Non-scoringCRI / S&P 9.98% / 13.34% | Non-scoringCRI / S&P 13.50 / 26.70 | Non-scoringCRI / S&P 4.16 / 4.43 | Non-scoringCRI / S&P CRI unavailable / $3.63m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.11b |
| 2021-Q11/3 |
LoseCRI / S&P -5.46% / 6.17% |
LoseCRI / S&P -8.03% / -1.06% |
WinCRI / S&P 90.85% / 7.39% |
Non-scoringCRI / S&P 8.70% / 11.60% | Non-scoringCRI / S&P 14.41 / 30.50 | Non-scoringCRI / S&P 3.84 / 4.23 | Non-scoringCRI / S&P CRI unavailable / $3.63m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.10b |
| 2020-Q40/3 |
LoseCRI / S&P 8.65% / 12.15% |
LoseCRI / S&P -14.06% / -3.72% |
LoseCRI / S&P -57.61% / -33.42% |
Non-scoringCRI / S&P 3.63% / 8.86% | Non-scoringCRI / S&P 37.54 / 39.26 | Non-scoringCRI / S&P 4.39 / 4.05 | Non-scoringCRI / S&P CRI unavailable / $3.17m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.01b |
| 2020-Q30/3 |
LoseCRI / S&P 7.29% / 8.93% |
LoseCRI / S&P -10.56% / -2.04% |
LoseCRI / S&P -48.63% / -27.10% |
Non-scoringCRI / S&P 4.33% / 9.24% | Non-scoringCRI / S&P 28.06 / 34.27 | Non-scoringCRI / S&P 4.64 / 3.65 | Non-scoringCRI / S&P CRI unavailable / $3.17m | Non-scoringCRI / S&P CRI unavailable / $0.02b | Non-scoringCRI / S&P CRI unavailable / $0.00b |
| 2020-Q21/3 |
WinCRI / S&P 22.78% / 20.54% |
LoseCRI / S&P -7.82% / -0.46% |
LoseCRI / S&P -58.68% / -27.11% |
Non-scoringCRI / S&P 3.57% / 9.37% | Non-scoringCRI / S&P 29.12 / 31.29 | Non-scoringCRI / S&P 4.56 / 3.44 | Non-scoringCRI / S&P CRI unavailable / $3.17m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.03b |
| 2020-Q10/3 |
LoseCRI / S&P -39.49% / -19.60% |
LoseCRI / S&P -0.43% / 3.47% |
LoseCRI / S&P -44.12% / -14.75% |
Non-scoringCRI / S&P 4.39% / 10.68% | Non-scoringCRI / S&P 20.16 / 22.80 | Non-scoringCRI / S&P 4.24 / 2.92 | Non-scoringCRI / S&P CRI unavailable / $3.17m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.05b |
| 2019-Q41/3 |
WinCRI / S&P 20.46% / 9.07% |
LoseCRI / S&P 1.65% / 5.36% |
LoseCRI / S&P -2.66% / 2.99% |
Non-scoringCRI / S&P 7.50% / 12.81% | Non-scoringCRI / S&P 18.34 / 22.78 | Non-scoringCRI / S&P 5.50 / 3.53 | Non-scoringCRI / S&P CRI unavailable / $3.08m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.05b |
| 2019-Q30/3 |
LoseCRI / S&P -5.98% / 1.70% |
LoseCRI / S&P 2.98% / 5.02% |
LoseCRI / S&P -2.82% / 0.21% |
Non-scoringCRI / S&P 7.68% / 12.41% | Non-scoringCRI / S&P 14.48 / 22.44 | Non-scoringCRI / S&P 4.80 / 3.30 | Non-scoringCRI / S&P CRI unavailable / $3.08m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.09b |
| 2019-Q20/3 |
LoseCRI / S&P -2.68% / 4.30% |
LoseCRI / S&P -28.21% / 6.64% |
LoseCRI / S&P -2.58% / 8.65% |
Non-scoringCRI / S&P 8.05% / 12.79% | Non-scoringCRI / S&P 15.59 / 21.37 | Non-scoringCRI / S&P 5.29 / 3.32 | Non-scoringCRI / S&P CRI unavailable / $3.08m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.27b |
| 2019-Q11/3 |
WinCRI / S&P 24.16% / 13.65% |
LoseCRI / S&P -38.56% / 8.12% |
LoseCRI / S&P -5.17% / 14.29% |
Non-scoringCRI / S&P 7.95% / 12.97% | Non-scoringCRI / S&P 16.69 / 20.86 | Non-scoringCRI / S&P 5.38 / 3.26 | Non-scoringCRI / S&P CRI unavailable / $3.08m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $34.35b |
| 2018-Q40/3 |
LoseCRI / S&P -16.81% / -13.52% |
LoseCRI / S&P -38.05% / 9.05% |
LoseCRI / S&P -3.84% / 18.23% |
Non-scoringCRI / S&P 8.15% / 13.10% | Non-scoringCRI / S&P 13.19 / 19.39 | Non-scoringCRI / S&P 4.28 / 2.94 | Non-scoringCRI / S&P CRI unavailable / $3.00m | Non-scoringCRI / S&P CRI unavailable / $0.01b | Non-scoringCRI / S&P CRI unavailable / $0.00b |
| 2018-Q30/3 |
LoseCRI / S&P -8.65% / 7.71% |
LoseCRI / S&P CRI unavailable / 10.21% |
LoseCRI / S&P 16.63% / 19.06% |
Non-scoringCRI / S&P 8.45% / 13.01% | Non-scoringCRI / S&P 15.78 / 22.25 | Non-scoringCRI / S&P 5.60 / 3.45 | Non-scoringCRI / S&P CRI unavailable / $3.00m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.17b |
| 2018-Q22/3 |
WinCRI / S&P 4.54% / 3.43% |
LoseCRI / S&P CRI unavailable / 9.03% |
WinCRI / S&P 22.73% / 14.46% |
Non-scoringCRI / S&P 6.14% / 12.56% | Non-scoringCRI / S&P 16.93 / 22.49 | Non-scoringCRI / S&P 6.23 / 3.25 | Non-scoringCRI / S&P CRI unavailable / $3.00m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.19b |
| 2018-Q11/3 |
LoseCRI / S&P -11.05% / -0.76% |
LoseCRI / S&P CRI unavailable / 7.68% |
WinCRI / S&P 23.80% / 12.46% |
Non-scoringCRI / S&P 5.32% / 12.27% | Non-scoringCRI / S&P 16.42 / 23.41 | Non-scoringCRI / S&P 5.74 / 3.17 | Non-scoringCRI / S&P CRI unavailable / $3.00m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.08b |
| 2017-Q42/3 |
WinCRI / S&P 19.40% / 6.64% |
LoseCRI / S&P CRI unavailable / 7.03% |
WinCRI / S&P 22.79% / 13.82% |
Non-scoringCRI / S&P 5.42% / 12.09% | Non-scoringCRI / S&P 18.30 / 24.25 | Non-scoringCRI / S&P 6.46 / 3.23 | Non-scoringCRI / S&P CRI unavailable / $2.92m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.05b |
| 2017-Q31/3 |
WinCRI / S&P 11.50% / 4.48% |
LoseCRI / S&P CRI unavailable / 5.68% |
LoseCRI / S&P 9.30% / 17.57% |
Non-scoringCRI / S&P CRI unavailable / 12.04% | Non-scoringCRI / S&P 18.48 / 23.28 | Non-scoringCRI / S&P 6.07 / 3.08 | Non-scoringCRI / S&P CRI unavailable / $2.92m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.11b |
| 2017-Q20/3 |
LoseCRI / S&P -0.49% / 3.09% |
LoseCRI / S&P CRI unavailable / 4.83% |
LoseCRI / S&P 9.05% / 17.74% |
Non-scoringCRI / S&P CRI unavailable / 11.96% | Non-scoringCRI / S&P 16.94 / 23.40 | Non-scoringCRI / S&P 5.69 / 3.03 | Non-scoringCRI / S&P CRI unavailable / $2.92m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.08b |
| 2017-Q10/3 |
LoseCRI / S&P 4.39% / 6.07% |
LoseCRI / S&P CRI unavailable / 3.67% |
LoseCRI / S&P 8.46% / 13.32% |
Non-scoringCRI / S&P CRI unavailable / 11.75% | Non-scoringCRI / S&P 17.40 / 23.60 | Non-scoringCRI / S&P 5.64 / 3.01 | Non-scoringCRI / S&P CRI unavailable / $2.92m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $20.24b |
| 2016-Q41/3 |
LoseCRI / S&P -0.01% / 3.82% |
LoseCRI / S&P CRI unavailable / 2.09% |
WinCRI / S&P 12.86% / 7.05% |
Non-scoringCRI / S&P CRI unavailable / 11.37% | Non-scoringCRI / S&P 16.41 / 23.76 | Non-scoringCRI / S&P 5.36 / 2.91 | Non-scoringCRI / S&P CRI unavailable / $2.88m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $1.11b |
| 2016-Q31/3 |
LoseCRI / S&P -18.28% / 3.85% |
LoseCRI / S&P CRI unavailable / 0.20% |
WinCRI / S&P 7.26% / -3.15% |
Non-scoringCRI / S&P CRI unavailable / 10.82% | Non-scoringCRI / S&P 17.67 / 24.22 | Non-scoringCRI / S&P 5.54 / 2.78 | Non-scoringCRI / S&P CRI unavailable / $2.88m | Non-scoringCRI / S&P CRI unavailable / $0.00b | Non-scoringCRI / S&P CRI unavailable / $0.16b |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | CRI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 19.37% | 20.78% |
| Annualized return | 19.37% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | CRI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -60.64% | 83.14% |
| Annualized return | -17.01% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | CRI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -54.52% | 319.30% |
| Annualized return | -7.58% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
- Net margin, P/E, P/B and other gray context columns never enter the score.
Snapshot captured 2026-09-04.